
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : OPT101
Therapeutic Area : Nephrology
Study Phase : IND Enabling
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Opterion Health Seeks Approval for First-in-Human OPT101 Study in Advanced CKD
Details : OPT101 is a novel non-glucose-based osmotic agent bringing much-needed new therapy options to patients with renal failure.
Product Name : OPT101
Product Type : Undisclosed
Upfront Cash : Inapplicable
September 17, 2025
Lead Product(s) : OPT101
Therapeutic Area : Nephrology
Highest Development Status : IND Enabling
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
